Epidemiology and Trends of Obesity and Bariatric Surgery in Korea.

IF 3.9 3区医学 Q2 ENDOCRINOLOGY & METABOLISM

Endocrinology and Metabolism Pub Date : 2024-10-01 Epub Date: 2024-08-02 DOI:10.3803/EnM.2024.2056

Kyungdo Han, Jin-Hyung Jung, Su-Min Jeong, Mee Kyoung Kim

引用次数: 0

Abstract

The prevalence of obesity in Korea has steadily increased over the past decade, reaching 38.4% in 2021. Notably, the rate of class II- III obesity, defined as a body mass index (BMI) of 30 kg/m2 or higher, exceeded 7% in the same year. Since January 2019, the National Health Insurance Service (NHIS) has provided coverage for bariatric surgery (BS) for eligible patients. Coverage is available for individuals with a BMI of 35 kg/m2 or higher, or those with a BMI of 30 kg/m2 or higher who also have obesity-related comorbidities. Additionally, partial reimbursement is offered for BS in patients with type 2 diabetes mellitus who have BMI values between 27.5 and 30 kg/m2. From 2019 to 2022, the NHIS recorded 9,080 BS procedures, with sleeve gastrectomy being the most commonly performed. The average percentage of weight loss 198±99.7 days post-surgery was 17.9%, with 80.0% of patients losing more than 10% of their body weight. This article presents the trends in obesity and BS in Korea.

查看原文本刊更多论文

韩国肥胖症和减肥手术的流行病学和发展趋势。

在过去十年中，韩国的肥胖症发病率稳步上升，2021 年达到 38.4%。值得注意的是，同年，体重指数（BMI）达到或超过 30 kg/m2 的 II-III 级肥胖率超过了 7%。自 2019 年 1 月起，国家健康保险服务（NHIS）为符合条件的患者提供减肥手术（BS）保险。体重指数（BMI）达到或超过 35 kg/m2 或体重指数（BMI）达到或超过 30 kg/m2 且同时患有肥胖相关合并症的患者均可享受该保险。此外，对 BMI 值在 27.5 至 30 kg/m2 之间的 2 型糖尿病患者的 BS 提供部分报销。从 2019 年到 2022 年，NHIS 共记录了 9080 例 BS 手术，其中袖状胃切除术最为常见。术后198±99.7天体重减轻的平均百分比为17.9%，80.0%的患者体重减轻超过10%。本文介绍了韩国肥胖症和 BS 的发展趋势。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Endocrinology and Metabolism Medicine-Endocrinology, Diabetes and Metabolism

CiteScore

6.60

自引率

5.90%

发文量

145

审稿时长

24 weeks

期刊介绍： The aim of this journal is to set high standards of medical care by providing a forum for discussion for basic, clinical, and translational researchers and clinicians on new findings in the fields of endocrinology and metabolism. Endocrinology and Metabolism reports new findings and developments in all aspects of endocrinology and metabolism. The topics covered by this journal include bone and mineral metabolism, cytokines, developmental endocrinology, diagnostic endocrinology, endocrine research, dyslipidemia, endocrine regulation, genetic endocrinology, growth factors, hormone receptors, hormone action and regulation, management of endocrine diseases, clinical trials, epidemiology, molecular endocrinology, neuroendocrinology, neuropeptides, neurotransmitters, obesity, pediatric endocrinology, reproductive endocrinology, signal transduction, the anatomy and physiology of endocrine organs (i.e., the pituitary, thyroid, parathyroid, and adrenal glands, and the gonads), and endocrine diseases (diabetes, nutrition, osteoporosis, etc.).